| 8952 | A | 203182 | 002 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | FRESENIUS KABI USA | EQ 10MG BASE/ML | AP | ["AP"] | 2015-02-26 | Feb 26, 2015 | No | No | No | RX | FRESENIUS KABI USA LLC | 2e13c49760d378fc4081b0cf6bca8b836cec902f6fa2c23b39aa2c15713464a5 |
| 8953 | A | 204960 | 001 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | JIANGSU HENGRUI MED | EQ 2MG BASE/ML | AP | ["AP"] | 2017-01-27 | Jan 27, 2017 | No | No | No | RX | JIANGSU HENGRUI MEDICINE CO LTD | ebd1638737ab86d260b2572ab39b7ea77ef914b573ddaea4e4670a682ca43ffe |
| 8954 | A | 204960 | 002 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | JIANGSU HENGRUI MED | EQ 10MG BASE/ML | AP | ["AP"] | 2017-09-19 | Sep 19, 2017 | No | No | No | RX | JIANGSU HENGRUI MEDICINE CO LTD | 21c9dc16a17a1678931db282bb54281747faf4d9bf72d505cd4ea46c3dd07e0c |
| 8955 | A | 200154 | 001 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | SANDOZ INC | EQ 2MG BASE/ML | AP | ["AP"] | 2012-02-03 | Feb 3, 2012 | No | No | No | RX | SANDOZ INC | 3c1bef764621cb176549ad042d2d748ff9aea7ce0c1545bfe740ba47f8855f51 |
| 8956 | A | 200154 | 002 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | SANDOZ INC | EQ 10MG BASE/ML | AP | ["AP"] | 2012-02-03 | Feb 3, 2012 | No | No | No | RX | SANDOZ INC | 73875286e47692a5eba7aa205ce436f9d455aa96ab0c46c1132fd0fbe1991f59 |
| 8957 | A | 206791 | 001 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | SOMERSET THERAPS LLC | EQ 2MG BASE/ML | AP | ["AP"] | 2019-02-20 | Feb 20, 2019 | No | No | No | RX | SOMERSET THERAPEUTICS LLC | 5508f56f4775290a1c22b7487ecbf628af0d898a6857d486431fce52bf7f2a15 |
| 8958 | A | 206791 | 002 | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISATRACURIUM BESYLATE PRESERVATIVE FREE | SOMERSET THERAPS LLC | EQ 10MG BASE/ML | AP | ["AP"] | 2019-02-20 | Feb 20, 2019 | No | No | No | RX | SOMERSET THERAPEUTICS LLC | fafdba134b03732df602349be92e9619c975343bb578d85b282a632b74235b24 |
| 8959 | A | 206774 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | ACCORD HLTHCARE | 1MG/ML | AP | ["AP"] | 2015-08-18 | Aug 18, 2015 | No | No | No | RX | ACCORD HEALTHCARE INC | 3bf4fd9049bf2f4cfceeb062f238f685e68d1974f4f5812a0bc58174fc8113ac |
| 8960 | A | 074713 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | BEDFORD | 10MG/VIAL | | [] | 2000-11-14 | Nov 14, 2000 | No | No | No | DISCN | BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC | 1c5c213eec5563a32a11a6ec9eafb8be90ade20c594e37e528dff1ba196672bb |
| 8961 | A | 074713 | 002 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | BEDFORD | 50MG/VIAL | | [] | 2000-11-14 | Nov 14, 2000 | No | No | No | DISCN | BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC | 525132d7e2569159d3ddd8ef5461b0fcc655b69b1dcb455fb0d7f3bd2ec544f2 |
| 8962 | A | 074735 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | FRESENIUS KABI USA | 1MG/ML | AP | ["AP"] | 1999-07-16 | Jul 16, 1999 | No | No | Yes | RX | FRESENIUS KABI USA LLC | 18220cdbf4e97ca54d5f78d6c7a91eb25e3493f6f0efa11953540dea0703c02f |
| 8963 | A | 207323 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | GLAND PHARMA LTD | 1MG/ML | AP | ["AP"] | 2017-03-17 | Mar 17, 2017 | No | No | No | RX | GLAND PHARMA LTD | 81daf3f100bf53594beef1a8fa1e836599bdd2fa12451addd00fb48eb88fefc1 |
| 8964 | N | 018057 | 004 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | HQ SPCLT PHARMA | 1MG/ML | AP | ["AP"] | 1988-11-08 | Nov 8, 1988 | No | Yes | No | RX | HQ SPECIALTY PHARMA CORP | 223fab1cd1a33e0cd625aa395a5bd662f0ef67c75af0163884652c29e9f00c48 |
| 8965 | A | 091062 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | MYLAN LABS LTD | 1MG/ML | | [] | 2012-04-18 | Apr 18, 2012 | No | No | No | DISCN | MYLAN LABORATORIES LTD | bbeb70a815f181b7542b06a759fb87493eb567db1180acc405504e07dcab5a0e |
| 8966 | A | 074656 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | PHARMACHEMIE BV | 1MG/ML | AP | ["AP"] | 2000-05-16 | May 16, 2000 | No | No | No | RX | PHARMACHEMIE BV | b6f0437f83e81f91315ff62afaf61033d48b69780a9a89e1236ae675b219e331 |
| 8967 | A | 074814 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | TEVA PHARMS USA | 1MG/ML | | [] | 2000-05-16 | May 16, 2000 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA | c21ac012ed2fa133030c1978b25735d71fb5a3c96503fc16cf940a8ddc230635 |
| 8968 | A | 075036 | 001 | CISPLATIN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CISPLATIN | WEST-WARD PHARMS INT | 1MG/ML | AP | ["AP"] | 2000-11-07 | Nov 7, 2000 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 8f92dd5630c327cd2d327a03d51404f1f9164204a5fd55b87a659756642dc8b8 |
| 8969 | N | 014763 | 004 | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST | ASTRAZENECA | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | ASTRAZENECA LP | 7bd3ef5fa4ce10e9e062d40d4114e03534901f98e7ca0b147def0516b938be27 |
| 8970 | N | 014763 | 005 | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST | ASTRAZENECA | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | ASTRAZENECA LP | b47ab5f572d7cf9b8cc1011b367b83819b36d9ac0fd0a144155804fe215cf44e |
| 8971 | N | 014763 | 003 | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST | ASTRAZENECA | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | ASTRAZENECA LP | a38b48dc460204207d279494e1383f198d156c4e4191b808b71aac2a104b2c07 |
| 8972 | N | 014763 | 008 | EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST FORTE | ASTRAZENECA | 0.005MG/ML;4% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ASTRAZENECA LP | 7841cf181f36cc3bd971f44ea364143666ad1bb4ae59d01e8a21696e865c6f8d |
| 8973 | N | 021383 | 001 | EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST FORTE DENTAL | DENTSPLY PHARM | 0.005MG/ML;4% | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | DENTSPLY PHARMACEUTICAL INC | 1abdfbeceac2bc6507640d13459fe65bea4de0572a095f1c8471ad09bf58d6e0 |
| 8974 | N | 014763 | 007 | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST PLAIN | ASTRAZENECA | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | ASTRAZENECA LP | 4f18d701cdff420951e06814aaf0fe9d42f8c0e5bb0aacdd98c0374d84b1e9bf |
| 8975 | N | 021382 | 001 | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CITANEST PLAIN DENTAL | DENTSPLY PHARM | 4% | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | DENTSPLY PHARMACEUTICAL INC | 29f3ef66942f7d8678876fa6186e6947f28617ecfee848114bf2992962cc03cd |
| 8976 | A | 076571 | 001 | CLADRIBINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLADRIBINE | FRESENIUS KABI USA | 1MG/ML | AP | ["AP"] | 2004-04-22 | Apr 22, 2004 | No | No | Yes | RX | FRESENIUS KABI USA LLC | 8e12863e9e8cf3e126eb2a77db63aaaec655615547301f846570773d1561848a |
| 8977 | A | 210856 | 001 | CLADRIBINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLADRIBINE | HISUN PHARM HANGZHOU | 1MG/ML | AP | ["AP"] | 2019-11-25 | Nov 25, 2019 | No | No | No | RX | HISUN PHARMACEUTICAL (HANGZHOU) CO LTD | 0cf159ae337175fc6b2575d8e30363e5e08c73766c348cccd2ff0415cfd91609 |
| 8978 | A | 200510 | 001 | CLADRIBINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLADRIBINE | MYLAN LABS LTD | 1MG/ML | AP | ["AP"] | 2011-10-06 | Oct 6, 2011 | No | No | No | RX | MYLAN LABORATORIES LTD | a2880c63076b929f462d4aa090ea81b2136c1ec1e8bc2f569a9d96fb655b181c |
| 8979 | A | 075405 | 001 | CLADRIBINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLADRIBINE | WEST-WARD PHARMS INT | 1MG/ML | AP | ["AP"] | 2000-02-28 | Feb 28, 2000 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 3f4659bf0e509b0718bbd24791a0769d6620f74e57d9909db24baee9ada36cca |
| 8980 | A | 062659 | 001 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN | SANOFI AVENTIS US | EQ 1GM BASE/VIAL | | [] | 1987-01-13 | Jan 13, 1987 | No | No | No | DISCN | SANOFI AVENTIS US LLC | 7d8e8b058c71c593abf188c57f24761836af4a3dcdf6c78ad0a51efb1377528a |
| 8981 | A | 062659 | 002 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN | SANOFI AVENTIS US | EQ 2GM BASE/VIAL | | [] | 1987-01-13 | Jan 13, 1987 | No | No | No | DISCN | SANOFI AVENTIS US LLC | f7db6437f92c51f559ac88b19ac7d192821da96822a925e51196822d8cba8e2a |
| 8982 | N | 050547 | 002 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN | VALIDUS PHARMS | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | VALIDUS PHARMACEUTICALS LLC | 000de80b0f25b59f9e4b84104e6f2e39f1c3a8494dc6711383d73602aa63772c |
| 8983 | N | 050547 | 003 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN | VALIDUS PHARMS | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | VALIDUS PHARMACEUTICALS LLC | 379424ac24ccd3d8b7a5d32de5f53ccd4fc88582d055cd493e73e1a8c9f199c7 |
| 8984 | N | 050547 | 004 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN | VALIDUS PHARMS | EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1983-12-29 | Dec 29, 1983 | No | Yes | No | DISCN | VALIDUS PHARMACEUTICALS LLC | dfd01873d9945e86eb71608c397124cd25ad4b0714cb4476a8d3723c0c735630 |
| 8985 | N | 050547 | 001 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN | VALIDUS PHARMS | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | VALIDUS PHARMACEUTICALS LLC | 98b54dfe00325424c12805cd70caa6313cca0730a944becd8ecec45007eacf2d |
| 8986 | N | 050596 | 002 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | VALIDUS PHARMS | EQ 20MG BASE/ML | | [] | 1985-05-20 | May 20, 1985 | No | No | No | DISCN | VALIDUS PHARMACEUTICALS LLC | 43bfdafa270d1d3ba711fb0d637e4808d804b20ba1fa1817312ecd13e8391612 |
| 8987 | N | 050596 | 004 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER | VALIDUS PHARMS | EQ 40MG BASE/ML | | [] | 1985-05-20 | May 20, 1985 | No | No | No | DISCN | VALIDUS PHARMACEUTICALS LLC | 4121edc184929c4ca64c22343ad5279ed6274b440a9d5b0e947d23d0a89f9eda |
| 8988 | N | 050596 | 001 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | VALIDUS PHARMS | EQ 20MG BASE/ML | | [] | 1985-05-20 | May 20, 1985 | No | No | No | DISCN | VALIDUS PHARMACEUTICALS LLC | 9d8aef779be0eef38038e829abe0dfef82fb0dc543fb35b776f786b4fa90f1ec |
| 8989 | N | 050596 | 003 | CEFOTAXIME SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | VALIDUS PHARMS | EQ 40MG BASE/ML | | [] | 1985-05-20 | May 20, 1985 | No | No | No | DISCN | VALIDUS PHARMACEUTICALS LLC | bdbfd28a6cbee46c8c867a1ffa9de4c6c2a667cde25b761d8364d82677e55991 |
| 8990 | A | 062803 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLEOCIN PHOSPHATE | PFIZER | EQ 150MG BASE/ML | AP | ["AP"] | 1987-10-16 | Oct 16, 1987 | No | No | No | RX | PFIZER INC | eb096df5718f52b8b369ce66eab79f7ca1621536035fc1fb18b0866f992baa45 |
| 8991 | N | 050441 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLEOCIN PHOSPHATE | PFIZER | EQ 150MG BASE/ML | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | PFIZER INC | 3746ed3385b753ef79e56d51ac14b57042bd849b5768baf3effe8e376bae84ec |
| 8992 | A | 061839 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLEOCIN PHOSPHATE | PHARMACIA AND UPJOHN | EQ 150MG BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PHARMACIA AND UPJOHN CO | e7115fe0d2efd859e8b842d25f1cd81375eb33fc3e71ff6c1bc3db4e26975fd3 |
| 8993 | N | 050639 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER | PFIZER | EQ 6MG BASE/ML | | [] | 1989-08-30 | Aug 30, 1989 | No | Yes | No | DISCN | PFIZER INC | 9972c7634763305a2f5c507cff83886cc305eb584233fa402185d8458fd3216d |
| 8994 | N | 050639 | 002 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER | PFIZER | EQ 12MG BASE/ML | | [] | 1989-08-30 | Aug 30, 1989 | No | Yes | No | DISCN | PFIZER INC | 361b74f555b111b67c7cd256d2ae645d6b0f4b7a85a091c664bcc7e8c91c4e4c |
| 8995 | N | 050639 | 003 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER | PFIZER | EQ 18MG BASE/ML | | [] | 1991-04-10 | Apr 10, 1991 | No | Yes | No | DISCN | PFIZER INC | 92215454a9059d8665c9b6dc904d5f8d05e775581e030f1c39aa9a55ba99e4da |
| 8996 | A | 062747 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLINDAMYCIN PHOSPHATE | ABRAXIS PHARM | EQ 150MG BASE/ML | | [] | 1988-06-03 | Jun 3, 1988 | No | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 0f97049233a28d1052b3a2dd9863b435f1a1abe9cc3f42e0ec0a2e5fd375fc26 |
| 8997 | A | 062800 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLINDAMYCIN PHOSPHATE | ALVOGEN | EQ 150MG BASE/ML | AP | ["AP"] | 1987-07-24 | Jul 24, 1987 | No | No | No | RX | ALVOGEN INC | 39f7b910a78f698d38203bb030e27b6975b81280fb0cf88a1985260986cf9f5d |
| 8998 | A | 062801 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLINDAMYCIN PHOSPHATE | ALVOGEN | EQ 150MG BASE/ML | | [] | 1987-07-24 | Jul 24, 1987 | No | No | No | DISCN | ALVOGEN INC | 281127628026bf853dac60ca20a744e93423e17ea0094b8c2a11173abe5a3470 |
| 8999 | A | 062943 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLINDAMYCIN PHOSPHATE | ALVOGEN | EQ 150MG BASE/ML | AP | ["AP"] | 1988-09-29 | Sep 29, 1988 | No | No | No | RX | ALVOGEN INC | 5fdb3c77ca1b86173105b889b384d2f99fd5e7b00a4980ec81785128389cb4ca |
| 9000 | A | 063163 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLINDAMYCIN PHOSPHATE | BEDFORD | EQ 150MG BASE/ML | | [] | 1994-06-30 | Jun 30, 1994 | No | No | No | DISCN | BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC | ca570581f2b6b91eaf7c432ec035eac7244f9636a281e22d96652e8488b2d51a |
| 9001 | A | 062908 | 001 | CLINDAMYCIN PHOSPHATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | CLINDAMYCIN PHOSPHATE | BRISTOL MYERS SQUIBB | EQ 150MG BASE/ML | | [] | 1989-02-01 | Feb 1, 1989 | No | No | No | DISCN | BRISTOL MYERS SQUIBB PHARMA CO | ec33ad8c26fb1a7d084b4a6893e4d4a38ef1c1c245ab17f3c1d9203d92bc2a45 |